The FTSE 100 is down today, but Halma investors aren’t panicking

With the FTSE 100 down, Halma’s share price has barely budged today after it announced acquisitions. Is it worth buying?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Life-saving technology group Halma (FTSE: HLMA) announced today that it had made another couple of acquisitions, NovaBone and FireMate. These will sit beside the other five companies bought by the group in its 2019 financial year. If you look back to at least 2014, there’s not one year in which it failed to make an acquisition.

The group increases its revenues and profits through a combination of acquisitions, partnerships and organic growth. Buying other companies is a fundamental part of its strategy, which has helped its share price go pretty much straight up for the last five years.

The shares’ longer-term performance is also encouraging. Shareholders enjoyed a total return of 1,141% from March 2009 to March 2019.

Fitting in

If the acquirer does its due diligence and doesn’t overpay for an acquisition that fits well with the company’s activities, then buying-in revenues and profits can add value for shareholders.

Of the two acquisitions announced today, one is a US-based designer and manufacturer of bone grafts, the other deals in cloud-based fire protection maintenance software for fire contractors.

Halma organises its businesses into four major segments: process, safety, infrastructure safety, environmental & analysis, and medical. The bone graft business fits nicely into the surgical applications subdivision of medical and the fire protection business slots into the fire subdivision of the infrastructure segment.

Looks like a bargain

NovaBone, the bone graft business, is being bought for approximately £74m in upfront cash, with up to £31m in add-ons depending on performance.

The group is paying about 14 to 20 times EBITDA for NovaBone (well below the 22.67 times average for the healthcare products industry). The price depends on performance and the new owner has forecast revenue and EBITDA of £16m and £5.3m respectively at its newly-acquired business. The price looks cheap to me.

Getting a 70% share of FireMate’s software business will cost Halma £6.2m upfront, with £3.3 in contingent payments. There’s an option to purchase the remaining shares exercisable in 2025.

Halma’s proportional share of FireMate’s last 12 months of EBIT would have been £0.35m and it’s paying 18 to 27 times EBIT for a controlling stake. Again, this multiple looks cheap compared to the 36 or 54 times EBIT averages paid for internet and system & application businesses.

The website Damodaran Online was used to find industry averages.

Not a bootstrapper

These are small acquisitions for Halma. Yet it’s encouraging to note that it doesn’t appear to be overpaying for businesses that fit well with existing operations.

Another issue with deal-hungry companies is that they sometimes buy growth to conceal weakness in their existing operations. According to Halma’s 2019 report, organic, constant currency growth ranged from 6.9% to 11.3% across its four divisions.

Organic, constant currency growth removes the distortions caused by acquisitions and exchange rate fluctuations. What it tells investors is that the group was growing well in 2019 before adding in acquired revenue. Since the pound weakened over the year, revenue growth on a non-constant-currency basis was even better.

At 2,161p, shares in Halma are not exactly cheap at 44 times consensus 2020 earnings of 49.6p. The forecast dividend yield is 0.8%, which is not awe-inspiring either. However, dividends and profits have grown by 7% and 13%, respectively, on average, over four years.

At the time of writing the FTSE 100 is down 2.4% but Halma’s share price has barely budged. For the long-term investor, the share looks like a good deal to me.

James J. McCombie has no position in any of the shares mentioned. The Motley Fool UK has recommended Halma. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

UK stocks: the contrarian choice for 2026

UK stocks aren’t the consensus choice for investors at the moment. But some smart money managers who are looking to…

Read more »

Investing Articles

Down 20% in 2025, shares in this under-the-radar UK defence tech firm could be set for a strong 2026

Cohort shares are down 20% this year, but NATO spending increases could offer UK investors a huge potential opportunity going…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »